INmune Bio, Inc. (NASDAQ:INMB) Receives Average Rating of “Hold” from Analysts

Shares of INmune Bio, Inc. (NASDAQ: INMB - Get Free Report) have been assigned a consensus rating of "Hold" from the six brokerages that are covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a sell rating, two have issued a hold rating, one has given a buy rating and one has